{"id":2234,"date":"2020-10-22T10:29:16","date_gmt":"2020-10-22T09:29:16","guid":{"rendered":"https:\/\/www.almacgroup.com\/diagnostics\/?post_type=diagnostic_resource&#038;p=2234"},"modified":"2020-10-22T10:30:43","modified_gmt":"2020-10-22T09:30:43","slug":"overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials","status":"publish","type":"diagnostic_resource","link":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/","title":{"rendered":"Overcoming the Challenges of Taking RNA Biomarkers into Clinical Trials"},"content":{"rendered":"\n<div class=\"wp-block-image\"><figure class=\"alignright size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/10\/Katarina-Wikstrom-Circle.png\" alt=\"\" class=\"wp-image-2235\" width=\"173\" height=\"173\" srcset=\"https:\/\/almacgroup.jp\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/10\/Katarina-Wikstrom-Circle.png 300w, https:\/\/almacgroup.jp\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/10\/Katarina-Wikstrom-Circle-150x150.png 150w\" sizes=\"(max-width: 173px) 100vw, 173px\" \/><figcaption>Featured speaker:<br><strong>Dr. Katarina Wikstrom<\/strong><br>Head of US Operations<br>Almac Diagnostic Services<br><br><\/figcaption><\/figure><\/div>\n\n\n\n<p>RNA Gene expression signatures (GESs) offer tremendous potential to classify patients into molecular subgroups of relevance for prognostic &amp; predictive utilities. However, variations in gene expression caused by technical imprecision in the analysis process, has led to uncertainty regarding the suitability of GES for clinical trial stratification.<\/p>\n\n\n\n<p>Download this complimentary webinar to explore key considerations in the development &amp; analytical validation of developing RNA biomarkers suitable for clinical stratification.<\/p>\n\n\n\n<p>Topics in this presentation include:<\/p>\n\n\n\n<ul><li>Lessons learned during the development &amp; validation of an in-house developed Next Generation Sequencing (NGS) gene expression signature<\/li><li>Supporting evidence for Gene Expression Signature suitability for clinical trials<\/li><li>Innovative reporting of GES with a software solution<\/li><\/ul>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-1 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n<\/div>\n\n\n\n<!--[if lte IE 8]>\n<script charset=\"utf-8\" type=\"text\/javascript\" src=\"\/\/js.hsforms.net\/forms\/v2-legacy.js\"><\/script>\n<![endif]-->\n<script charset=\"utf-8\" type=\"text\/javascript\" src=\"\/\/js.hsforms.net\/forms\/v2.js\"><\/script>\n<script>\n  hbspt.forms.create({\n\tportalId: \"742105\",\n\tformId: \"a837c2dd-b2d6-4d3a-ab87-feb9fb88655c\"\n});\n<\/script>\n","protected":false},"featured_media":0,"template":"","diagnostics_type":[474],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.2 (Yoast SEO v23.2) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Overcoming the Challenges of Taking RNA Biomarkers into Clinical Trials - Diagnostic Services<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Overcoming the Challenges of Taking RNA Biomarkers into Clinical Trials\" \/>\n<meta property=\"og:description\" content=\"RNA Gene expression signatures (GESs) offer tremendous potential to classify patients into molecular subgroups of relevance for prognostic &amp; predictive utilities. However, variations in gene expression caused by technical imprecision in the analysis process, has led to uncertainty regarding the suitability of GES for clinical trial stratification. Download this complimentary webinar to explore key considerations [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"Diagnostic Services\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-22T09:30:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/10\/Katarina-Wikstrom-Circle.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/\",\"url\":\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/\",\"name\":\"Overcoming the Challenges of Taking RNA Biomarkers into Clinical Trials - Diagnostic Services\",\"isPartOf\":{\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/10\/Katarina-Wikstrom-Circle.png\",\"datePublished\":\"2020-10-22T09:29:16+00:00\",\"dateModified\":\"2020-10-22T09:30:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/#primaryimage\",\"url\":\"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/10\/Katarina-Wikstrom-Circle.png\",\"contentUrl\":\"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/10\/Katarina-Wikstrom-Circle.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/almacgroup.jp\/diagnostics\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Overcoming the Challenges of Taking RNA Biomarkers into Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/#website\",\"url\":\"https:\/\/www.almacgroup.com\/diagnostics\/\",\"name\":\"Diagnostic Services\",\"description\":\"Just another Almac Core Sites site\",\"publisher\":{\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.almacgroup.com\/diagnostics\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/#organization\",\"name\":\"Almac Group Ltd\",\"url\":\"https:\/\/www.almacgroup.com\/diagnostics\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/04\/almac-logo-with-strapline.jpg\",\"contentUrl\":\"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/04\/almac-logo-with-strapline.jpg\",\"width\":643,\"height\":296,\"caption\":\"Almac Group Ltd\"},\"image\":{\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Overcoming the Challenges of Taking RNA Biomarkers into Clinical Trials - Diagnostic Services","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/","og_locale":"en_GB","og_type":"article","og_title":"Overcoming the Challenges of Taking RNA Biomarkers into Clinical Trials","og_description":"RNA Gene expression signatures (GESs) offer tremendous potential to classify patients into molecular subgroups of relevance for prognostic &amp; predictive utilities. However, variations in gene expression caused by technical imprecision in the analysis process, has led to uncertainty regarding the suitability of GES for clinical trial stratification. Download this complimentary webinar to explore key considerations [&hellip;]","og_url":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/","og_site_name":"Diagnostic Services","article_modified_time":"2020-10-22T09:30:43+00:00","og_image":[{"url":"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/10\/Katarina-Wikstrom-Circle.png"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/","url":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/","name":"Overcoming the Challenges of Taking RNA Biomarkers into Clinical Trials - Diagnostic Services","isPartOf":{"@id":"https:\/\/www.almacgroup.com\/diagnostics\/#website"},"primaryImageOfPage":{"@id":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/#primaryimage"},"image":{"@id":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/10\/Katarina-Wikstrom-Circle.png","datePublished":"2020-10-22T09:29:16+00:00","dateModified":"2020-10-22T09:30:43+00:00","breadcrumb":{"@id":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/#primaryimage","url":"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/10\/Katarina-Wikstrom-Circle.png","contentUrl":"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/10\/Katarina-Wikstrom-Circle.png"},{"@type":"BreadcrumbList","@id":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/overcoming-the-challenges-of-taking-rna-biomarkers-into-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/almacgroup.jp\/diagnostics\/"},{"@type":"ListItem","position":2,"name":"Overcoming the Challenges of Taking RNA Biomarkers into Clinical Trials"}]},{"@type":"WebSite","@id":"https:\/\/www.almacgroup.com\/diagnostics\/#website","url":"https:\/\/www.almacgroup.com\/diagnostics\/","name":"Diagnostic Services","description":"Just another Almac Core Sites site","publisher":{"@id":"https:\/\/www.almacgroup.com\/diagnostics\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.almacgroup.com\/diagnostics\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.almacgroup.com\/diagnostics\/#organization","name":"Almac Group Ltd","url":"https:\/\/www.almacgroup.com\/diagnostics\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.almacgroup.com\/diagnostics\/#\/schema\/logo\/image\/","url":"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/04\/almac-logo-with-strapline.jpg","contentUrl":"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/04\/almac-logo-with-strapline.jpg","width":643,"height":296,"caption":"Almac Group Ltd"},"image":{"@id":"https:\/\/www.almacgroup.com\/diagnostics\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/almacgroup.jp\/diagnostics\/wp-json\/wp\/v2\/diagnostic_resource\/2234"}],"collection":[{"href":"https:\/\/almacgroup.jp\/diagnostics\/wp-json\/wp\/v2\/diagnostic_resource"}],"about":[{"href":"https:\/\/almacgroup.jp\/diagnostics\/wp-json\/wp\/v2\/types\/diagnostic_resource"}],"wp:attachment":[{"href":"https:\/\/almacgroup.jp\/diagnostics\/wp-json\/wp\/v2\/media?parent=2234"}],"wp:term":[{"taxonomy":"diagnostics_type","embeddable":true,"href":"https:\/\/almacgroup.jp\/diagnostics\/wp-json\/wp\/v2\/diagnostics_type?post=2234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}